Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10552-020-01311-2.pdf
Reference35 articles.
1. Chien FL, Schwartz SM, Johnson RH (2014) Increase in testicular germ cell tumor incidence among Hispanic adolescents and young adults in the United States. Cancer 120:2728–2734
2. Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S (2015) Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol 33:623–631
3. Townsend JS, Richardson LC, German RR (2010) Incidence of testicular cancer in the United States, 1999–2004. Am J Men's Health 4:353–360
4. American Cancer Society (2019) Cancer Facts & Figures 2019. American Cancer Society, Atlanta
5. Ghazarian AA, Trabert B, Graubard BI, Schwartz SM, Altekruse SF, McGlynn KA (2015) Incidence of testicular germ cell tumors among US men by census region. Cancer 121:4181–4189
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Survival outcomes and molecular drivers of testicular cancer in hispanic men;Urologic Oncology: Seminars and Original Investigations;2024-09
2. Understanding Sociodemographic Factors among Hispanics Through a Population-Based Study on Testicular Cancer in Mexico;Journal of Racial and Ethnic Health Disparities;2023-11-14
3. Traffic-related Air Pollution and Lung Cancer Incidence: The California Multiethnic Cohort Study;American Journal of Respiratory and Critical Care Medicine;2022-10-15
4. Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy;Cancers;2022-04-20
5. Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study;Therapeutic Advances in Medical Oncology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3